Abstract

PurposePersistent fatigue among colorectal cancer (CRC) patients might be associated with unfavorable body composition, but data are sparse and inconsistent. We studied how skeletal muscle index (SMI), skeletal muscle radiodensity (SMR), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) at diagnosis are associated with fatigue up to 24 months post-diagnosis in stage I–III CRC patients.MethodsSMI, SMR, VAT, and SAT were assessed among 646 CRC patients using pre-treatment computed tomography images. Fatigue at diagnosis, at 6, and 24 months post-diagnosis was assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire. The association of SMI, SMR, VAT, and SAT with fatigue (yes/no) was assessed using confounder-adjusted restricted cubic spline analyses.ResultsPrevalence of fatigue at diagnosis was 18%, at 6 months 25%, and at 24 months 12%. At diagnosis, a significant (p = 0.01) non-linear association of higher levels of SAT with higher prevalence of fatigue was observed. Lower levels of SMR were linearly associated with higher prevalence of fatigue at 6 months post-diagnosis (overall association p = 0.02). None of the body composition parameters were significantly associated with fatigue at 24 months.ConclusionHaving more SAT was associated with more fatigue at diagnosis, while low levels of SMR were associated with more fatigue at 6 months post-diagnosis.Implications for Cancer SurvivorsOur results suggest that it may be interesting to investigate whether interventions that aim to increase SMR around the time of diagnosis may help to lower fatigue. However, more knowledge is needed to understand the mechanisms behind the association of SMR with fatigue.

Highlights

  • Fatigue is highly prevalent among stage I–III colorectal cancer (CRC) patients

  • The aim of the current study was to investigate the association of body composition parameters (Skeletal Muscle Index (SMI), skeletal muscle radiodensity (SMR), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT)) at diagnosis with fatigue at three timepoints in stage I–III CRC patients

  • The study population consisted of 960 patients, of which we had to exclude 192 patients because no suitable computed tomography (CT) image was available; 68 patients because of stage IV disease; 11 patients because of missing information on stage of disease; and 63 patients because no fatigue data at diagnosis were available (Fig. 1)

Read more

Summary

Introduction

Fatigue is highly prevalent among stage I–III colorectal cancer (CRC) patients. Fatigue is often already experienced before diagnosis [1] and can persist for years after treatment. The highest prevalence (up to 85%) of fatigue is seen during and shortly after treatment [2, 3], and the prevalence decreases in the years after treatment, up to 40% of CRC patients experience fatigue in the first 5 years after diagnosis [4]. Fatigue is one of the most debilitating side effects of cancer and has a substantial negative impact on mood, work, social relationships, and overall quality of life [2]. Fatigue has been associated with treatment (radio- and chemotherapy), stage of disease, presence of (multiple) comorbidities, specific medications with sedating side effects, psychological factors (e.g., depression), decreased

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call